Back
Delegates Premium Access

Statin intolerance in a real word setting of Italian cardiology centers: data from the BRING-UP Prevention study

Session: Dyslipidaemia management in 2025: status quo and best practice (1)
Topic: Drug therapy
Speaker: Doctor S. Di Fusco (Rome, IT)
Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Stefania Angela Di Fusco

San Filippo Neri Hospital, Rome (Italy)
0 follower

4 more presentations in this session

Does the length of evolocumab use contribute to myocardial infarction associated hospital readmissions in patients with ACS?: a single center real world evidence from ELAINE

Speaker: Doctor O. Wani (Flagstaff, US)

Access
Abstract
Slides
Like
Thumbnail

Deficient perceptions and practices concerning elevated lipoprotein(a) among specialists in Singapore

Speaker: Doctor W. Loh (Singapore, SG)

Access
Abstract
Slides
Like
Thumbnail

The prevalence and accumulation of main cardiometabolic risk factors among the finnish adult population at different levels of lp(a)

Speaker: Professor P. Jousilahti (Helsinki, FI)

Access
Abstract
Slides
Like
Thumbnail

A collaborative working project in primary care: optimising lipid lowering therapies for secondary prevention in high risk patients

Speaker: Doctor J. Ward (Westbury, GB)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Dyslipidaemia management in 2025: status quo and best practice (1)

Speakers: Doctor S. Di Fusco, Doctor O. Wani, Doctor W. Loh, Professor P. Jousilahti, Doctor J. Ward
Access
Like
Thumbnail

About the event

Image

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources